Inventor
NICHOLS DAVE
US12 patents
⚠️ This page may combine multiple inventors who share the name “NICHOLS DAVE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SHIRE HUMAN GENETIC THERAPIES
4 patentsUS9051556B2Jun 9, 2015
Purification of iduronate-2-sulfatase
SHIRE HUMAN GENETIC THERAPIES13 citations90
US9492511B2Nov 15, 2016
Methods and compositions for treatment of hunter syndrome
SHIRE HUMAN GENETIC THERAPIES4 citations82
US11530393B2Dec 20, 2022
Compositions comprising iduronate-2-sulfatase
SHIRE HUMAN GENETIC THERAPIES2 citations71
US10344270B2Jul 9, 2019
Methods and compositions for treatment of Hunter syndrome
SHIRE HUMAN GENETIC THERAPIES2 citations71
TAKEDA PHARMACEUTICALS CO
4 patentsUS12359178B2Jul 15, 2025
Methods and compositions for treatment of hunter syndrome comprising iduronate-2-sulfatase
TAKEDA PHARMACEUTICALS CO0 citations60
US12319940B2Jun 3, 2025
Methods for purification of arylsulfatase A
TAKEDA PHARMACEUTICALS CO0 citations56
US11884945B2Jan 30, 2024
Methods for purification of arylsulfatase A
TAKEDA PHARMACEUTICALS CO0 citations56
US11407984B2Aug 9, 2022
Methods for purification of arysulfatase A
TAKEDA PHARMACEUTICALS CO0 citations56
KINIKSA PHARMACEUTICALS LTD
3 patentsUS11141479B2Oct 12, 2021
Stable anti-OSMR antibody formulation
KINIKSA PHARMACEUTICALS LTD0 citations59
US10493149B2Dec 3, 2019
Stable anti-OSMR antibody formulation
KINIKSA PHARMACEUTICALS LTD0 citations47
US10391170B2Aug 27, 2019
Stable anti-OSMR antibody formulation
KINIKSA PHARMACEUTICALS LTD0 citations47